Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Vyndaqel 20 mg soft capsules {equilateral_black_triangle}

Active Ingredient:
tafamidis meglumine
Company:  
Pfizer Limited See contact details
ATC code: 
N07XX08
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Vyndaqel HCP Guide

{healthcare_pro_orange} For Healthcare Professionals
Healthcare professional guide to highlight key information related to prescribing, management, monitoring and safety considerations included in the Risk Management Plan

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pfizer Limited
Company image
Address
Ramsgate Road, Sandwich, Kent, CT13 9NJ
Telephone
+44 (0)1304 616 161
Medical Information Website
www.pfizermedicalinformation.co.uk
Medical Information Direct Line
+44 (0)1304 616161